ID: ALA5180563

Max Phase: Preclinical

Molecular Formula: C31H41N3O5S

Molecular Weight: 567.75

Associated Items:

Representations

Canonical SMILES:  C=C[C@]1(C)C[C@@H](OC(=O)CSc2nnc(-c3ccccc3OC)[nH]2)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O

Standard InChI:  InChI=1S/C31H41N3O5S/c1-7-29(4)16-23(30(5)18(2)12-14-31(19(3)26(29)37)15-13-21(35)25(30)31)39-24(36)17-40-28-32-27(33-34-28)20-10-8-9-11-22(20)38-6/h7-11,18-19,23,25-26,37H,1,12-17H2,2-6H3,(H,32,33,34)/t18-,19+,23-,25+,26+,29-,30+,31+/m1/s1

Standard InChI Key:  SKFATBOJRLFNCI-ZIMDNTAOSA-N

Associated Targets(Human)

16HBE14o- (68 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rpsB Bacterial 70S ribosome (328 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RAW264.7 (28094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 567.75Molecular Weight (Monoisotopic): 567.2767AlogP: 5.48#Rotatable Bonds: 7
Polar Surface Area: 114.40Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 7.99CX Basic pKa: 1.42CX LogP: 4.88CX LogD: 4.79
Aromatic Rings: 2Heavy Atoms: 40QED Weighted: 0.26Np Likeness Score: 0.95

References

1. Wang X, Wang R, Zhang ZS, Zhang GY, Jin Z, Shen R, Du D, Tang YZ..  (2022)  Semisynthetic pleuromutilin antimicrobials with therapeutic potential against methicillin-resistant Staphylococcus aureus by targeting 50S ribosomal subunit.,  237  [PMID:35430480] [10.1016/j.ejmech.2022.114341]

Source